Health Care: Drugs

Cleveland BioLabs Inc (CBLI: NASDAQ)

$2.52 n/a | n/a%
06/24/16 - 02:48 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 2.71M 3.70M 8.49M 3.57M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 2.71M 3.70M 8.49M 3.57M
Selling, General, and Administrative Expenses 6.36M 8.47M 12.04M 11.12M
Research & Development 7.14M 9.65M 19.53M 22.50M
Operating Income before D & A (EBITDA) -10.79M -14.42M -23.08M -30.05M
Depreciation & Amortization 275.22K 841.04K 471.21K 479.60K
Interest Income 0.00 0.00 83.13K 0.00
Other Income - Net -1.79M 15.83M 2.86M 7.70M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -13.22M 283.91K -20.60M -22.82M
Interest Expense 99.49K 1.09M 0.00 70.02K
Pre-Tax Income -13.32M -805.67K -20.60M -22.89M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -407.28K -1.59M -2.87M -4.18M
Net Income From Continuing Operations -13.04M 35.37K -20.13M -22.41M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -13.04M 35.37K -20.13M -22.41M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -12.64M 1.63M -17.26M -18.23M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-13.04M 35.37K -20.13M -22.41M
Preferred Dividends
Net Income Available To Common -13.04M 35.37K -20.13M -22.41M
Basic EPS from Continuing Ops. -1.79 0.60 -7.67 -9.75
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.79 0.60 -7.67 -9.75
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.07 -0.05
Basic EPS, Total -1.79 0.60 -7.60 -9.80
Basic Normalized Net Income/Share -1.79 0.60 -7.67 -9.75
EPS fr Continuing Ops. -1.79 0.60 -7.67 -9.75
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.79 0.60 -7.67 -9.75
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.07 -0.05
EPS, Total -1.79 0.60 -7.60 -9.80
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.79 0.60 -7.67 -9.75
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CBLI

Latest CBLI Headlines from TheStreet

More Financial News for CBLI

Press Releases for CBLI

See All Press Releases

Partner Headlines for CBLI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter